Home > Products > 1020172-07-9

1020172-07-9
2-Pyridinecarboxamide, 4-[4-[[[[3-(1,1-dimethylethyl)-1-(6-quinolinyl)-1H-pyrazol-5-yl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-

Catalog#:1P0006SI

CAS:1020172-07-9

MDL:MFCD19443646

Molecular Formula:C30H28FN7O3

Molecular Weight:553.5868

UN Number:

Haz Class:

Packing Group:

Synonyms: DCC-2036; REBASTINIB; DCC2036; 4-[4-({[3-Tert-Butyl-1-(Quinolin-6-Yl)-1h-Pyrazol-5-Yl]carbamoyl}amino)-3-Fluorophenoxy]-N-Methylpyridine-2-Carboxamide; DP-1919; 75017Q6I97; 4-[4-[(5-tert-butyl-2-quinolin-6-ylpyrazol-3-yl)carbamoylamino]-3-fluorophenoxy]-N-methylpyridine-2-carboxamide; 1-[3-tert-butyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl]-3-{2-fluoro-4-[2-(methylcarbamoyl)pyridin-4-yloxy]phenyl}urea; 4-(4-(3-(3-tert-butyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl)ureido)-3-fluorophenoxy)-N-methylpicolinamide; 4-[4-[(5-Tert-butyl-2-quinolin-6-ylpyrazol-3-yl)carbamoylamino]-3-fluorophenoxy]-N-methylpyridine-2-carboxamide,4-methylbenzenesulfonic acid;4-[4-[(5-Tert-butyl-2-quinolin-6-ylpyrazol-3-yl)carbamoylamino]-3-fluorophenoxy]-N-methylpyridine-2-carboxamide,4-methylbenzenesulfonic acid; N-[3-tert-Butyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl]-N'-[2-fluoro-4-[(2-(methylcarbamoyl)pyridin-4-yl)oxy]phenyl]urea; Rebastinib [USAN:INN]; DCC-2036; 3qri; 3qrj; Rebastinib (USAN); DP 1919; Rebastinib/DCC-2036; DCC-2036; Rebastinib; Rebastinib (DCC-2036); Rebastinib(DCC-2036 ); cc-606; MLS006011270; 1020172-07-9; GTPL9173; SCHEMBL2034290; CHEMBL1738757; C30H28FN7O3; DTXSID40144533; QCR-201; BDBM185674; HMS3656H07; AOB87733; BCP02345; DCC-2036 (Rebastinib); EX-A2046; KS-00001D3R; ABP001004; ABP001046; MFCD19443646; s2634; ZINC63933734; AKOS025404839; BCP9000591; CS-1038; DCC 2036; DB13005; SB16618; NCGC00263172-01; NCGC00263172-09; AC-30301; AK174792; AS-17048; BC261917; HY-13024; SMR004703020; CHEBI:62166; AB0033775; FT-0760974; SW219251-1; X7511; J3.653.310B; D10334; W-5814; DCC 2036, DCC2036, 357263-13-9; 2-Pyridinecarboxamide, 4-[4-[[[[3-(1,1-dimethylethyl)-1-(6-quinolinyl)-1H-pyrazol-5-yl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-; 4-[4-({[5-tert-butyl-2-(quinolin-6-yl)pyrazol-3-yl]carbamoyl}amino)-3-fluorophenoxy]-N-methylpyridine-2-carboxamide; UNII-75017Q6I97; Rebastinib [USAN]; REBASTINIB TOSYLATE; D0E0NM; DCC-2618; B1404; A11200; C560099; 1033893-29-6; 1225278-16-9; 357263-13-9; Rebastinib(DCC-2036); 4-(4-(3-(3-(tert-butyl)-1-(quinolin-6-yl)-1H-pyrazol-5-yl)ureido)-3-fluorophenoxy)-N-methylpicolinamide;

Keywords: 1020172-07-9,MFCD19443646,1P0006SI,2-Pyridinecarboxamide, 4-[4-[[[[3-(1,1-dimethylethyl)-1-(6-quinolinyl)-1H-pyrazol-5-yl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-,C30H28FN7O3

Inquire
Catalog# Purity Size Price Dis. Price Availability Quantity
1P0006SI 95% 10mg $172.00 $129.00 In Stock USA ADD TO CART BUY NOW

Copyright C 2019 1PlusChem LLC. All Right Reserved